Pharmaceutical Technology on MSN17 天
USPTO allows patents for Remedy’s large hemispheric infarction drug
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating LHI.